130.93
7.11 (5.74%)
| Penutupan Terdahulu | 123.82 |
| Buka | 123.39 |
| Jumlah Dagangan | 899,511 |
| Purata Dagangan (3B) | 973,215 |
| Modal Pasaran | 4,474,443,776 |
| Harga / Pendapatan (P/E TTM) | 51.55 |
| Harga / Pendapatan (P/E Ke hadapan) | 60.98 |
| Harga / Jualan (P/S) | 10.08 |
| Harga / Buku (P/B) | 14.05 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 29 Oct 2025 |
| Margin Keuntungan | 10.03% |
| Margin Operasi (TTM) | 19.12% |
| EPS Cair (TTM) | 1.42 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 48.20% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | 110.60% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 194.67% |
| Nisbah Semasa (MRQ) | 9.10 |
| Aliran Tunai Operasi (OCF TTM) | 49.38 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -84.81 M |
| Pulangan Atas Aset (ROA TTM) | 4.21% |
| Pulangan Atas Ekuiti (ROE TTM) | 22.99% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Devices (US) | Bercampur | Bercampur |
| Medical Devices (Global) | Bercampur | Bercampur | |
| Stok | TransMedics Group, Inc. | Menaik | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | 1.5 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -0.5 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | 4.0 |
| Purata | 1.25 |
|
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation. |
|
| Sektor | Healthcare |
| Industri | Medical Devices |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 3.03% |
| % Dimiliki oleh Institusi | 121.56% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 155.00 (Evercore ISI Group, 18.38%) | Beli |
| Median | 146.00 (11.51%) | |
| Rendah | 135.00 (Morgan Stanley, 3.11%) | Pegang |
| Purata | 145.00 (10.75%) | |
| Jumlah | 5 Beli, 1 Pegang | |
| Harga Purata @ Panggilan | 129.62 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Morgan Stanley | 02 Dec 2025 | 135.00 (3.11%) | Pegang | 146.38 |
| Canaccord Genuity | 30 Oct 2025 | 147.00 (12.27%) | Beli | 135.79 |
| 14 Oct 2025 | 142.00 (8.45%) | Beli | 111.23 | |
| Piper Sandler | 30 Oct 2025 | 140.00 (6.93%) | Beli | 135.79 |
| Needham | 23 Oct 2025 | 148.00 (13.04%) | Beli | 128.91 |
| Jefferies | 13 Oct 2025 | 145.00 (10.75%) | Beli | 111.71 |
| Evercore ISI Group | 16 Sep 2025 | 155.00 (18.38%) | Beli | 119.15 |
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 18 Nov 2025 | Pengumuman | TransMedics to Participate in the Piper Sandler 37th Annual Healthcare Conference |
| 31 Oct 2025 | Pengumuman | TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) |
| 29 Oct 2025 | Pengumuman | TransMedics Reports Third Quarter 2025 Financial Results |
| 15 Oct 2025 | Pengumuman | TransMedics to Report Third Quarter 2025 Financial Results on October 29, 2025 |
| 22 Sep 2025 | Pengumuman | TransMedics and Mercedes-Benz Announce Strategic Collaboration to Launch First Dedicated Organ Transplantation Ground Transportation Network in Italy |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |